There are 381 resources available
189P - Assessment of seroconversion after SARS-CoV2 vaccination in patients with lung cancer
Presenter: Ioannis Trontzas
Session: Poster Display session
190P - COVID-19 pandemic impact on lung cancer patient’s performance status and access to treatment: A comparative study pre and during COVID-19 era
Presenter: Rute Fernandes
Session: Poster Display session
191P - Lung cancer care in Europe during COVID-19: Findings from a global survey of patient experience
Presenter: Jackie Fenemore
Session: Poster Display session
195P - Radiomics and dosiomics signature from whole lung predicts radiation pneumonitis : A model development study with prospective external validation and decision-curve analysis
Presenter: Zhen Zhang
Session: Poster Display session
184P - Early-stage diagnosis of lung cancer with liquid biopsy test based on peripheral blood cells
Presenter: Andreas Thomsen
Session: Poster Display session
186P - CIP2A modulates PKM2 dimer-tetramer transition through phosphorylation of serine 287 in non-small cell lung cancer
Presenter: lijun Liang
Session: Poster Display session
181P - Anlotinib enhances the antitumor activity of high‑dose irradiation combined with anti‑PD-L1 by potentiating the tumor immune microenvironment in murine lung cancer
Presenter: Meng Yuan
Session: Poster Display session
183P - Predictor value of PD-L1 for radiotherapy response in locally advanced non-small cell lung cancer
Presenter: Volkan Demircan
Session: Poster Display session
187P - Development of a magnetic nanostructure for co-delivery of metformin and silibinin on growth of lung cancer cells: Possible action through leptin gene and its receptor regulation
Presenter: Davoud Jafari-Gharabaghlou
Session: Poster Display session
180P - Schwann cells promotes tumour progression in small cell lung cancer
Presenter: Sophie cao
Session: Poster Display session